SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction

Hartmut Porst, Arthur Burnett, Gerald Brock, Hussein Ghanem, Francois Giuliano, Sidney Glina, Wayne Hellstrom, Antonio Martin-Morales, Andrea Salonia, Ira Sharlip

Research output: Contribution to journalArticle

Abstract

Introduction. Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male self-esteem and nearly all life domains including interpersonal, family, and business relationships. Aim. The aim of this study is to provide an updated overview on currently used and available conservative treatment options for ED with a special focus on their efficacy, tolerability, safety, merits, and limitations including the role of combination therapies for monotherapy failures. Methods. The methods used were PubMed and MEDLINE searches using the following keywords: ED, phosphodiesterase type 5 (PDE5) inhibitors, oral drug therapy, intracavernosal injection therapy, transurethral therapy, topical therapy, and vacuum-erection therapy/constriction devices. Additionally, expert opinions by the authors of this article are included. Results. Level 1 evidence exists that changes in sedentary lifestyle with weight loss and optimal treatment of concomitant diseases/risk factors (e.g., diabetes, hypertension, and dyslipidemia) can either improve ED or add to the efficacy of ED-specific therapies, e.g., PDE5 inhibitors. Level 1 evidence also exists that treatment of hypogonadism with total testosterone

Original languageEnglish (US)
Pages (from-to)130-171
Number of pages42
JournalJournal of Sexual Medicine
Volume10
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Erectile Dysfunction
Phosphodiesterase 5 Inhibitors
Therapeutics
Sedentary Lifestyle
Hypogonadism
Expert Testimony
Dyslipidemias
Vacuum
PubMed
Self Concept
Constriction
MEDLINE
Testosterone
Weight Loss
Hypertension
Safety
Drug Therapy
Equipment and Supplies
Injections

Keywords

  • Combination Therapies
  • Erectile Dysfunction
  • Intracavernous Self-Injection Therapy
  • Oral Drug Treatment
  • Phosphodiesterase Inhibitors
  • Transurethral Alprostadil Therapy
  • Vacuum Device Therapy

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Porst, H., Burnett, A., Brock, G., Ghanem, H., Giuliano, F., Glina, S., ... Sharlip, I. (2013). SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction. Journal of Sexual Medicine, 10(1), 130-171. https://doi.org/10.1111/jsm.12023

SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction. / Porst, Hartmut; Burnett, Arthur; Brock, Gerald; Ghanem, Hussein; Giuliano, Francois; Glina, Sidney; Hellstrom, Wayne; Martin-Morales, Antonio; Salonia, Andrea; Sharlip, Ira.

In: Journal of Sexual Medicine, Vol. 10, No. 1, 01.2013, p. 130-171.

Research output: Contribution to journalArticle

Porst, H, Burnett, A, Brock, G, Ghanem, H, Giuliano, F, Glina, S, Hellstrom, W, Martin-Morales, A, Salonia, A & Sharlip, I 2013, 'SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction', Journal of Sexual Medicine, vol. 10, no. 1, pp. 130-171. https://doi.org/10.1111/jsm.12023
Porst, Hartmut ; Burnett, Arthur ; Brock, Gerald ; Ghanem, Hussein ; Giuliano, Francois ; Glina, Sidney ; Hellstrom, Wayne ; Martin-Morales, Antonio ; Salonia, Andrea ; Sharlip, Ira. / SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction. In: Journal of Sexual Medicine. 2013 ; Vol. 10, No. 1. pp. 130-171.
@article{fce35244d75a4a699d8ae7d3e4674dc8,
title = "SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction",
abstract = "Introduction. Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male self-esteem and nearly all life domains including interpersonal, family, and business relationships. Aim. The aim of this study is to provide an updated overview on currently used and available conservative treatment options for ED with a special focus on their efficacy, tolerability, safety, merits, and limitations including the role of combination therapies for monotherapy failures. Methods. The methods used were PubMed and MEDLINE searches using the following keywords: ED, phosphodiesterase type 5 (PDE5) inhibitors, oral drug therapy, intracavernosal injection therapy, transurethral therapy, topical therapy, and vacuum-erection therapy/constriction devices. Additionally, expert opinions by the authors of this article are included. Results. Level 1 evidence exists that changes in sedentary lifestyle with weight loss and optimal treatment of concomitant diseases/risk factors (e.g., diabetes, hypertension, and dyslipidemia) can either improve ED or add to the efficacy of ED-specific therapies, e.g., PDE5 inhibitors. Level 1 evidence also exists that treatment of hypogonadism with total testosterone",
keywords = "Combination Therapies, Erectile Dysfunction, Intracavernous Self-Injection Therapy, Oral Drug Treatment, Phosphodiesterase Inhibitors, Transurethral Alprostadil Therapy, Vacuum Device Therapy",
author = "Hartmut Porst and Arthur Burnett and Gerald Brock and Hussein Ghanem and Francois Giuliano and Sidney Glina and Wayne Hellstrom and Antonio Martin-Morales and Andrea Salonia and Ira Sharlip",
year = "2013",
month = "1",
doi = "10.1111/jsm.12023",
language = "English (US)",
volume = "10",
pages = "130--171",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction

AU - Porst, Hartmut

AU - Burnett, Arthur

AU - Brock, Gerald

AU - Ghanem, Hussein

AU - Giuliano, Francois

AU - Glina, Sidney

AU - Hellstrom, Wayne

AU - Martin-Morales, Antonio

AU - Salonia, Andrea

AU - Sharlip, Ira

PY - 2013/1

Y1 - 2013/1

N2 - Introduction. Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male self-esteem and nearly all life domains including interpersonal, family, and business relationships. Aim. The aim of this study is to provide an updated overview on currently used and available conservative treatment options for ED with a special focus on their efficacy, tolerability, safety, merits, and limitations including the role of combination therapies for monotherapy failures. Methods. The methods used were PubMed and MEDLINE searches using the following keywords: ED, phosphodiesterase type 5 (PDE5) inhibitors, oral drug therapy, intracavernosal injection therapy, transurethral therapy, topical therapy, and vacuum-erection therapy/constriction devices. Additionally, expert opinions by the authors of this article are included. Results. Level 1 evidence exists that changes in sedentary lifestyle with weight loss and optimal treatment of concomitant diseases/risk factors (e.g., diabetes, hypertension, and dyslipidemia) can either improve ED or add to the efficacy of ED-specific therapies, e.g., PDE5 inhibitors. Level 1 evidence also exists that treatment of hypogonadism with total testosterone

AB - Introduction. Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male self-esteem and nearly all life domains including interpersonal, family, and business relationships. Aim. The aim of this study is to provide an updated overview on currently used and available conservative treatment options for ED with a special focus on their efficacy, tolerability, safety, merits, and limitations including the role of combination therapies for monotherapy failures. Methods. The methods used were PubMed and MEDLINE searches using the following keywords: ED, phosphodiesterase type 5 (PDE5) inhibitors, oral drug therapy, intracavernosal injection therapy, transurethral therapy, topical therapy, and vacuum-erection therapy/constriction devices. Additionally, expert opinions by the authors of this article are included. Results. Level 1 evidence exists that changes in sedentary lifestyle with weight loss and optimal treatment of concomitant diseases/risk factors (e.g., diabetes, hypertension, and dyslipidemia) can either improve ED or add to the efficacy of ED-specific therapies, e.g., PDE5 inhibitors. Level 1 evidence also exists that treatment of hypogonadism with total testosterone

KW - Combination Therapies

KW - Erectile Dysfunction

KW - Intracavernous Self-Injection Therapy

KW - Oral Drug Treatment

KW - Phosphodiesterase Inhibitors

KW - Transurethral Alprostadil Therapy

KW - Vacuum Device Therapy

UR - http://www.scopus.com/inward/record.url?scp=84872875076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872875076&partnerID=8YFLogxK

U2 - 10.1111/jsm.12023

DO - 10.1111/jsm.12023

M3 - Article

C2 - 23343170

AN - SCOPUS:84872875076

VL - 10

SP - 130

EP - 171

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 1

ER -